RMD vs. CLS.TO
RMD (ResMed Inc.) and CLS.TO (Celestica Inc.) are both stocks. RMD operates in Medical Instruments & Supplies (Healthcare), while CLS.TO operates in Electronic Components (Technology). Over the past 10 years, RMD returned 13.85%/yr vs 43.71%/yr for CLS.TO. At a 0.21 correlation, their price movements are largely independent.
Performance
RMD vs. CLS.TO - Performance Comparison
Loading charts...
Different Trading Currencies
RMD is traded in USD, while CLS.TO is traded in CAD. To make them comparable, the CLS.TO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, RMD achieves a -18.71% return, which is significantly lower than CLS.TO's 32.76% return. Over the past 10 years, RMD has underperformed CLS.TO with an annualized return of 13.85%, while CLS.TO has yielded a comparatively higher 43.71% annualized return.
RMD
- 1D
- 1.24%
- 1M
- -3.46%
- YTD
- -18.71%
- 6M
- -22.38%
- 1Y
- -22.01%
- 3Y*
- -2.26%
- 5Y*
- -1.41%
- 10Y*
- 13.85%
CLS.TO
- 1D
- 1.99%
- 1M
- 5.68%
- YTD
- 32.76%
- 6M
- 28.56%
- 1Y
- 202.30%
- 3Y*
- 207.61%
- 5Y*
- 116.14%
- 10Y*
- 43.71%
RMD vs. CLS.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RMD ResMed Inc. | -18.71% | 6.26% | 34.18% | -16.55% | -19.47% | 23.41% | 38.33% | 37.85% | 36.38% | 39.06% |
CLS.TO Celestica Inc. | 32.69% | 220.69% | 215.14% | 160.52% | 1.78% | 37.36% | -2.32% | -6.08% | -16.29% | -11.14% |
Correlation
The correlation between RMD and CLS.TO is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jul 12, 2006 | 0.21 |
The correlation between RMD and CLS.TO shifts across timeframes, from 0.04 (1 year) to 0.21 (all time), reflecting how their relationship changes across market environments.
Fundamentals
RMD:
$13.78
CLS.TO:
$8.28
RMD:
14.14
CLS.TO:
47.51
RMD:
0.44
CLS.TO:
0.64
RMD:
3.88
CLS.TO:
3.30
RMD:
$5.54B
CLS.TO:
$13.81B
RMD:
$3.42B
CLS.TO:
$1.60B
RMD:
$2.10B
CLS.TO:
$1.36B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RMD vs. CLS.TO — Risk / Return Rank
RMD
CLS.TO
RMD vs. CLS.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and Celestica Inc. (CLS.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RMD | CLS.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.75 | ||
| Sortino ratioReturn per unit of downside risk | -4.02 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.38 | -0.52 |
| Calmar ratioReturn relative to maximum drawdown | -0.59 | 6.89 | -7.48 |
| Martin ratioReturn relative to average drawdown | -1.34 | 17.06 | -18.40 |
Loading charts...
Drawdowns
RMD vs. CLS.TO - Drawdown Comparison
The maximum RMD drawdown since its inception was -61.61%, smaller than the maximum CLS.TO drawdown of -80.63%. Use the drawdown chart below to compare losses from any high point for RMD and CLS.TO.
Loading charts...
Drawdown Indicators
| RMD | CLS.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.61% | -80.63% | +19.02% |
Max Drawdown (1Y)Largest decline over 1 year | -37.28% | -29.56% | -7.72% |
Max Drawdown (3Y)Largest decline over 3 years | -40.09% | -53.42% | +13.33% |
Max Drawdown (5Y)Largest decline over 5 years | -53.99% | -53.42% | -0.57% |
Max Drawdown (10Y)Largest decline over 10 years | -53.99% | -80.63% | +26.64% |
Current DrawdownCurrent decline from peak | -33.18% | -16.56% | -16.62% |
Average DrawdownAverage peak-to-trough decline | -16.00% | -26.16% | +10.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.49% | 11.91% | +4.58% |
Volatility
RMD vs. CLS.TO - Volatility Comparison
The current volatility for ResMed Inc. (RMD) is 9.81%, while Celestica Inc. (CLS.TO) has a volatility of 28.03%. This indicates that RMD experiences smaller price fluctuations and is considered to be less risky than CLS.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RMD | CLS.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.81% | 28.03% | -18.22% |
Volatility (6M)Calculated over the trailing 6-month period | 19.30% | 55.40% | -36.10% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.09% | 72.00% | -47.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.07% | 56.84% | -25.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.54% | 49.39% | -17.85% |
Dividends
RMD vs. CLS.TO - Dividend Comparison
RMD's dividend yield for the trailing twelve months is around 1.23%, while CLS.TO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLS.TO Celestica Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RMD ResMed Inc. | 1.23% | 0.94% | 0.88% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% |
Financials
RMD vs. CLS.TO - Financials Comparison
This section allows you to compare key financial metrics between ResMed Inc. and Celestica Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RMD vs. CLS.TO - Profitability Comparison
RMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a gross profit of 890.98M and revenue of 1.43B. Therefore, the gross margin over that period was 62.3%.
CLS.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a gross profit of 437.20M and revenue of 4.05B. Therefore, the gross margin over that period was 10.8%.
RMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported an operating income of 499.81M and revenue of 1.43B, resulting in an operating margin of 34.9%.
CLS.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported an operating income of 267.70M and revenue of 4.05B, resulting in an operating margin of 6.6%.
RMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a net income of 398.73M and revenue of 1.43B, resulting in a net margin of 27.9%.
CLS.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a net income of 212.30M and revenue of 4.05B, resulting in a net margin of 5.3%.
Frequently Asked Questions
RMD and CLS.TO have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for RMD and CLS.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer